We are looking for children 2–17 years old to join a Crohn’s disease clinical research study to help us discover more about treating moderate to severe IBD. If you are looking for a potential new treatment option for moderate to severe IBD or moderate to severe IBD (including associated symptoms such as tiredness, fatigue, constant need to poop, malnutrition and/or canker sores), consider one of our GI clinical research studies. All eligible participants will receive no-cost study-related care and study medication. Your children 2–17 years old may be eligible to take part.
Your child may be eligible to take part in the GI clinical research studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Find out if your child qualifies.
